Infection Clinical Trials

56 recruiting

Infection Trials at a Glance

1,220 actively recruiting trials for infection are listed on ClinicalTrialsFinder across 6 cities in 118 countries. The largest study group is Not Applicable with 347 trials, with the heaviest enrollment activity in Houston, New York, and Philadelphia. Lead sponsors running infection studies include National Institute of Allergy and Infectious Diseases (NIAID), Assistance Publique - Hôpitaux de Paris, and University Hospital, Strasbourg, France.

Treatments under study

About Infection Clinical Trials

Looking for clinical trials for Infection? There are currently 56 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,220 trials

Recruiting

Modeling Host-Pathogen Interaction Using Lymphoid Organoids

Staphylococcal Infections
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled2 locationsNCT06479837
Recruiting

Host Response to Infection and Treatment in Filarial Diseases

HelminthiasisFilariasisParasitic Infection+2 more
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled1 locationNCT00001230
Recruiting

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

PneumoniaInfectionsImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT00006150
Recruiting
Phase 1

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

Congenital Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID)12 enrolled10 locationsNCT06118515
Recruiting

Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients

AnthraxBacillus Infections
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT00050310
Recruiting
Phase 1

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

HIV Infection
Merck Sharp & Dohme LLC28 enrolled2 locationsNCT07042945
Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting
Phase 2

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Chronic Hepatitis B Infection
Aligos Therapeutics200 enrolled58 locationsNCT06963710
Recruiting

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Pseudomonas Infections
Centre Hospitalier Régional d'Orléans600 enrolled48 locationsNCT06738771
Recruiting

Diagnosis and Management of Inflammatory and Infectious Diseases

InflammationInfection
National Institute of Allergy and Infectious Diseases (NIAID)400 enrolled1 locationNCT00557726
Recruiting

In-depth Immunological Investigation of COVID-19.

Coronavirus Infections
Universitaire Ziekenhuizen KU Leuven100 enrolled1 locationNCT04327570
Recruiting
Not Applicable

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

ObesityHIV-1-infection
University College Dublin80 enrolled1 locationNCT04174755
Recruiting
Phase 2

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

LymphomaEpstein-Barr Virus InfectionsLymphoproliferative Disorder+1 more
National Cancer Institute (NCI)40 enrolled1 locationNCT03258567
Recruiting

Evaluation of Patients With HAM/TSP

HTLV-I InfectionTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS)750 enrolled1 locationNCT00001778
Recruiting

Borrelia B-cell Diagnostics

Lyme DiseaseBorrelia Infections
University Children's Hospital, Zurich502 enrolled1 locationNCT06045416
Recruiting

Fungal Infection Susceptibility

Cryptococcal MeningitisCryptococcosisCryptococcal Infection+2 more
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled1 locationNCT00001352
Recruiting
Phase 1Phase 2

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled46 locationsNCT02140255
Recruiting
Early Phase 1

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

HIV-1-infection
University of California, San Diego138 enrolled1 locationNCT04883255
Recruiting
Not Applicable

Stop Sepsis Through Home Monitoring Cooperative

SepsisInfectionHome Monitoring Follow-up+1 more
University Hospital, Antwerp120 enrolled1 locationNCT06920979
Recruiting
Not Applicable

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

HIV InfectionsTraumaSubstance Use+1 more
University of California, San Diego300 enrolled1 locationNCT06216600